<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 14, 2000
Neogen Corporation
(Exact name of registrant as specified in its charter)
Michigan 0-17988 38-2367843
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
620 Lesher Place, Lansing, Michigan 48912
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (517) 372-9200
----------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
This Form 8-K/A amends the Form 8-K filed with the Securities and Exchange
Commission on June 16, 2000, by including the information in Item 7.
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS
On June 2, 2000, Neogen Corporation purchased substantially all of the assets of
AmVet Pharmaceuticals of Yaphank, New York. AmVet owns formulas for 25 different
veterinary products under approximately 40 labels, the majority of which are
sold under the AmVet name. There is no relationship between AmVet and Neogen or
any of their affiliates.
The consideration for the sale, which was determined through arms length
negotiations, subject to certain post closing adjustments, was $3,400,000, and
up to an additional $1,000,000 based on levels of post closing revenues. The
source of cash consideration was available Neogen cash balances.
Neogen intends to move the business to Lexington, Kentucky and integrate it with
its Animal Safety Division.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA INFORMATION AND EXHIBITS
(A) FINANCIAL STATEMENTS OF BUSINESS TO BE ACQUIRED AND (B) PRO FORMA
FINANCIAL INFORMATION
Financial statements and proforma financial statements of the business acquired
are not required by the applicable rules and regulations of the Securities and
Exchange Commission as the acquisition is not considered to be significant.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Neogen Corporation
(Registrant)
Date: August 14, 2000 By: /s/ Richard R. Current
-----------------------------
Richard R. Current
Vice President and CFO
2
